|
| 34511324 | Solute carrier transporters: emerging central players in tumour immunotherapy. | Trends Cell Biol | 2022 |
| 35469906 | Ablation of Proton/Glucose Exporter SLC45A2 Enhances Melanosomal Glycolysis to Inhibit Melanin Biosynthesis and Promote Melanoma Metastasis. | J Invest Dermatol | 2022 |
| 35530363 | Iron Transporters and Ferroptosis in Malignant Brain Tumors. | Front Oncol | 2022 |
| 36103816 | Embigin facilitates monocarboxylate transporter 1 localization to the plasma membrane and transition to a decoupling state. | Cell Rep | 2022 |
| 35152203 | Amino Acid Solute Carrier Transporters in Inflammation and Autoimmunity. | Drug Metab Dispos | 2022 |
| 34033814 | Aspirin inhibits prostaglandins to prevents colon tumor formation via down-regulating Wnt production. | Eur J Pharmacol | 2021 |
| 33882315 | SLC22A14 is a mitochondrial riboflavin transporter required for sperm oxidative phosphorylation and male fertility. | Cell Rep | 2021 |
| 33618219 | Efficient endothelial and smooth muscle cell differentiation from human pluripotent stem cells through a simplified insulin-free culture system. | Biomaterials | 2021 |
| 33895786 | An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. | Signal Transduct Target Ther | 2021 |
| 34433664 | SLC-30A9 is required for Zn<sup>2+</sup> homeostasis, Zn<sup>2+</sup> mobilization, and mitochondrial health. | Proc Natl Acad Sci U S A | 2021 |
| 30954949 | Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. | Gut | 2020 |
| 31993307 | Solute carrier transporters: the metabolic gatekeepers of immune cells. | Acta Pharm Sin B | 2020 |
| 32860752 | Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies. | Cancer Cell | 2020 |
| 32373195 | The solute carrier transporters and the brain: Physiological and pharmacological implications. | Asian J Pharm Sci | 2020 |
| 30653498 | Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue. | PLoS Biol | 2019 |
| 31686320 | Regulation of glucose and lipid metabolism in health and disease. | Sci China Life Sci | 2019 |
| 32035227 | DeepCPI: A Deep Learning-based Framework for Large-scale in silico Drug Screening. | Genomics Proteomics Bioinformatics | 2019 |
| 30239845 | The SLC transporter in nutrient and metabolic sensing, regulation, and drug development. | J Mol Cell Biol | 2019 |
| 31399282 | Slc6a8-Mediated Creatine Uptake and Accumulation Reprogram Macrophage Polarization via Regulating Cytokine Responses. | Immunity | 2019 |
| 31534518 | Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System. | Theranostics | 2019 |
| 30760873 | mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis. | Cell Death Differ | 2019 |
| 30324491 | The zinc transporter Slc39a5 controls glucose sensing and insulin secretion in pancreatic β-cells via Sirt1- and Pgc-1α-mediated regulation of Glut2. | Protein Cell | 2019 |
| 28871336 | Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. | Arch Toxicol | 2018 |
| 29659562 | Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content. | PLoS Biol | 2018 |
| 28924171 | A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. | Nat Commun | 2017 |
| 28397817 | Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity. | Sci Rep | 2017 |
| 28370287 | A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis. | Hepatology | 2017 |
| 27128978 | Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening. | ACS Chem Biol | 2016 |
| 26467480 | A deep learning framework for modeling structural features of RNA-binding protein targets. | Nucleic Acids Res | 2016 |
| 27260449 | Establishment of local searching methods for orbitrap-based high throughput metabolomics analysis. | Talanta | 2016 |
| 25590948 | OCT1 in hepatic steatosis and thiamine disposition. | Cell Cycle | 2015 |
| 26396683 | Discovery of Imidazo[1,2-α][1,8]naphthyridine Derivatives as Potential HCV Entry Inhibitor. | ACS Med Chem Lett | 2015 |
| 25920679 | Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin. | Mol Pharmacol | 2015 |
| 25797421 | The physiological role of drug transporters. | Protein Cell | 2015 |
| 24961373 | OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. | Proc Natl Acad Sci U S A | 2014 |
| 22231567 | Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3. | Pharmacogenomics J | 2013 |
| 22456732 | The role of ATM in response to metformin treatment and activation of AMPK. | Nat Genet | 2012 |
| 20567254 | Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions. | Pharmacogenomics J | 2011 |
| 21111751 | GABAA receptor open-state conformation determines non-competitive antagonist binding. | Toxicol Appl Pharmacol | 2011 |
| 20371711 | Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue. | Mol Cancer Ther | 2010 |
| 20859243 | Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin. | Pharmacogenet Genomics | 2010 |
| 20943911 | Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. | J Neurosci | 2010 |
| 20639304 | Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function. | J Pharmacol Exp Ther | 2010 |
| 20350125 | Pharmacogenomics of membrane transporters: past, present and future. | Pharmacogenomics | 2010 |
| 19483665 | Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin. | Pharmacogenet Genomics | 2009 |
| 19742321 | Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation. | PLoS One | 2009 |
| 16537435 | Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site. | Proc Natl Acad Sci U S A | 2006 |
| 17050528 | Spontaneous mobility of GABAA receptor M2 extracellular half relative to noncompetitive antagonist action. | J Biol Chem | 2006 |